Carisoprodol
- Product NDC
- 51525-5901
- 11-digit product format
- 515255901
- Labeler code
- 51525
- Product ID
- 51525-5901_8c92753a-4b60-4ecf-b411-d66665ae493e
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- carisoprodol
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Mylan Pharmaceuticals Inc.
- Application
- NDA011792
- Marketing category
- NDA AUTHORIZED GENERIC
- Marketing start
- 2016-10-01
- Substance
- CARISOPRODOL
- Active strength
- 250 mg/1
- Pharmacologic classes
- Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]
- DEA schedule
- CIV
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Carisoprodol
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| CARISOPRODOL | 250 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 21925K482H |
| Rxcui | 730794 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 51525-5901-1 | Carisoprodol | 100 in 1 BOTTLE | TABLET | 100 | | 10 |
DailyMed Socrata Ingredients#
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 51525-5901 | CARISOPRODOL TABLET [WALLACE PHARMACEUTICALS INC.] | 8 | Current NDC, Legacy NDC, 1 package rows | 20250311_7c9184c0-7a2e-11df-8c8d-0002a5d5c51b.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 51525-5901-1 | 51525590101 | 100 TABLET in 1 BOTTLE (51525-5901-1) | 100 tablet | 2016-10-01 | 0000-00-00 | No | No | Current |